Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cliintel Capital is a venture capital firm founded in 2015 by Richard Michael Batenburg Jr. and Richard Michael Batenburg III. The firm is headquartered in Greenwood Village, Colorado, and focuses on equipping growth-oriented companies across the cannabis supply chain and other emerging vice industries with essential tools and support. Since its inception, Cliintel has emphasized a people-driven approach to investing, aiming to connect ideas, people, and resources to create value.
As of now, Cliintel Capital manages a portfolio of six companies and operates primarily in North America. The firm has established itself as a key player in the cannabis investment space, providing not only capital but also strategic consulting services to help companies navigate heavily regulated markets. Their expertise in corporate governance compliance and investor relations further enhances their value proposition to portfolio companies.
Cliintel Capital invests primarily in the cannabis sector and other emerging vice industries, including healthcare and consumer markets. The firm targets companies at various stages of growth, including seed, Series A, and growth equity. Their check sizes typically align with the needs of growth-oriented companies, providing both funding and strategic consulting services.
The firm’s investment strategy includes a strong emphasis on helping companies navigate the complexities of heavily regulated markets. Cliintel Capital offers services such as capital strategy, strategic partnerships, corporate governance compliance, and organizational structure support. They seek founders who are not only innovative but also possess a strong understanding of their market dynamics and regulatory challenges.
Cliintel Capital's portfolio includes six notable companies, each contributing to the firm's focus on the cannabis sector and other emerging vice industries:
These companies reflect Cliintel's commitment to investing in sectors that are often overlooked yet hold significant growth potential.
Richard M. Batenburg Jr. - Fund Manager: Richard has extensive experience in venture capital and has been instrumental in shaping Cliintel Capital's investment strategy since its founding.
Rick Batenburg - Chief Investment Officer: Rick brings a wealth of knowledge in investment management and has led several successful funding rounds for portfolio companies.
Monica Pina - SVP, Investor Relations: Monica is responsible for managing relationships with investors and ensuring effective communication between the firm and its stakeholders.
Cliintel Capital prefers pitches to be submitted via email to monica@cliintel.com. Founders should include a concise overview of their business, market opportunity, and how they plan to navigate regulatory challenges.
In recent months, Cliintel Capital has continued to expand its portfolio, focusing on companies within the cannabis sector and other emerging vice industries. The firm has been actively promoting its mission through its website and engaging with potential partners.
Cliintel Capital has also been involved in discussions regarding regulatory compliance and strategic partnerships, emphasizing its commitment to supporting portfolio companies in navigating complex market environments.
What are Cliintel Capital's investment criteria?
Cliintel Capital primarily invests in growth-oriented companies within the cannabis sector and other emerging vice industries. They focus on businesses that demonstrate strong potential for success in heavily regulated markets.
How can I pitch to Cliintel Capital?
Founders can pitch to Cliintel Capital by visiting their contact page at Cliintel Capital Contact. They encourage direct communication via email at monica@cliintel.com.
What makes Cliintel Capital different from other investors?
Cliintel Capital distinguishes itself through its people-driven approach, emphasizing strategic consulting alongside capital investment. They provide comprehensive support in navigating regulatory challenges.
What is the geographic focus of Cliintel Capital?
The firm primarily focuses on investments within North America, particularly in the cannabis sector and other emerging vice industries.
What stages of investment does Cliintel Capital engage in?
Cliintel Capital invests at various stages, including seed, Series A, and growth equity, allowing them to support companies throughout their development.
What kind of post-investment support does Cliintel Capital provide?
Cliintel Capital offers strategic consulting services post-investment, including assistance with corporate governance compliance, capital strategy, and organizational structure.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.